United States · Platforms & data · Morningstar

What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Published by Morningstar · United States 10 h ago

On August 4, 2026, Chemours announced second quarter 2026 financial results. Among other things, the Company reduced its adjusted EBITDA full-year guidance to $775 million to $825…

Read the full article on Morningstar Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

MarketBeat

Grab (NASDAQ:GRAB) Stock: Insider Philipp Wolfgang Josef Kandal Sells 30,000 Shares

Seeking Alpha

SpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stage

The Motley Fool

What Should The Chemours Company Investors Know After 18.63% Stock Drop? The Law Offices of Frank R. Cruz Outlines Securities Fraud Class Action Lead Plaintiff Deadline

Share

Also worth reading

Grab (NASDAQ:GRAB) Stock: Insider Philipp Wolfgang Josef Kandal Sells 30,000 Shares

SpaceX Q3 earnings: Revenue seen surging to $13B as AI business takes centre stage

Up 10% in the Last Two Weeks, Is Airbnb the Perfect Stock for Today's Market?

Three big takeaways from the IMF-World Bank meetings

Gold dips as oil prices fuel inflation fears, Fed outlook in focus

Blood clots are ‘incredibly common,’ even for pro athletes like Jalen Hurts. Here’s what to know.